Many reasons why we are reducing botulinum toxin / type A dosis
Recommended sessions
Industry symposium
S323 - Fidia Farmaceutici Symposium - The innovative approach with autologous tissue therapy: a journey from HA - ACP technology to SVF
Industry symposium
S215 - IBSA Farmaceutici Italia Symposium - Hybrid cooperative complex HA (Profhilo®): integrative, evidence based solution for multi-level tissue remodeling
S098 - Male combined treatments
S103, S104 - Injectables - Contributed talks
S041 - Late onset adverse reactions to injectables (in collaboration with gDEC)